Form 4 for NUTX Nutex Health Inc.
Accepted 2021-12-21 00:00:00 ET · period of report 2021-02-25 · accession 0001486189-21-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-02-25 | NUTX | Hosseinion Warren | CEO, Dir | J - Other | $2.04 | +894.2K | 1.15M | +347% | +$1.82M |
| DM | 2021-12-21 | 2019-03-19+ | NUTX | Hosseinion Warren | CEO, Dir | P - Purchase | $6.67 | +821.6K | 21.6K | New | +$5.48M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-25 | J | A | 894,209 | $2.04 | 1,151,563 | D | — | — | |
| 2 | Derivative | Director Stock Option (right to buy) | 2020-01-27 | P | A | 800,000 | — | 800,000 | D | — · — to — | 800,000 Common Stock | (F2) 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 |
| 3 | Derivative | Warrants to Puchase common stock | 2019-03-19 | P | A | 21,590 | $6.67 | 21,590 | D | $6.67 · 2019-03-19 to 2024-12-31 | 21,590 Common Stock |